| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 163 | 6,172,628 | ARGX, IONS, VRTX, ISRG | 13F-HR | 11/14/2024 | 000095012324011906 |
| Q2 2024 | 166 | 6,154,328 | IONS, ARGX, VRTX, NBIX | 13F-HR | 8/14/2024 | 000095012324008688 |
| Q1 2024 | 169 | 6,556,865 | IONS, ARGX, NBIX, VRTX | 13F-HR | 5/15/2024 | 000095012324005547 |
| Q4 2023 | 161 | 6,537,470 | IONS, ARGX, NBIX, VRTX | 13F-HR | 2/14/2024 | 000095012324002337 |
| Q3 2023 | 154 | 6,206,911 | ARGX, IONS, VRTX, NBIX | 13F-HR | 11/14/2023 | 000095012323010681 |
| Q2 2023 | 156 | 7,010,438 | VRTX, IONS, ARGX, ISRG | 13F-HR | 8/14/2023 | 000095012323007883 |
| Q1 2023 | 159 | 6,891,167 | VRTX, IONS, ARGX, NBIX | 13F-HR | 5/15/2023 | 000095012323004949 |
| Q4 2022 | 171 | 7,534,625 | IONS, ARGX, NBIX, VRTX | 13F-HR | 2/14/2023 | 000095012323002442 |
| Q3 2022 | 176 | 6,967,677 | IONS, VRTX, ARGX, NBIX | 13F-HR | 11/14/2022 | 000095012322012051 |
| Q2 2022 | 172 | 7,074,165 | IONS, ARGX, VRTX, NBIX | 13F-HR | 8/11/2022 | 000095012322008396 |
| Q1 2022 | 177 | 8,611,961 | VRTX, IONS, ARGX, NBIX | 13F-HR | 5/13/2022 | 000095012322005793 |
| Q4 2021 | 191 | 9,701,498 | MRNA, VRTX, ARGX, IONS | 13F-HR | 2/10/2022 | 000095012322001606 |
| Q3 2021 | 220 | 9,853,974 | MRNA, VRTX, IONS, ARGX | 13F-HR | 11/12/2021 | 000095012321014717 |
| Q2 2021 | 214 | 10,244,311 | MRNA, IONS, VRTX, NBIX | 13F-HR | 8/12/2021 | 000095012321010479 |
| Q1 2021 | 216 | 9,451,547 | IONS, MRNA, NBIX, VRTX | 13F-HR | 5/11/2021 | 000095012321005896 |
| Q4 2020 | 222 | 8,732,059 | IONS, NBIX, MRNA, VRTX | 13F-HR | 2/16/2021 | 000095012321002417 |
| Q3 2020 | 217 | 7,237,378 | IONS, NBIX, INCY, VRTX | 13F-HR | 11/16/2020 | 000095012320012188 |
| Q2 2020 | 208 | 7,065,908 | IONS, NBIX, INCY, VRTX | 13F-HR | 8/13/2020 | 000095012320008656 |
| Q1 2020 | 215 | 5,156,592 | IONS, VRTX, NBIX, INCY | 13F-HR | 5/14/2020 | 000095012320004900 |
| Q4 2019 | 216 | 6,307,401 | IONS, NBIX, INCY, VRTX | 13F-HR | 2/14/2020 | 000095012320002395 |
| Q3 2019 | 211 | 5,376,825 | IONS, NBIX, INCY, VRTX | 13F-HR | 11/14/2019 | 000095012319011454 |
| Q2 2019 | 201 | 5,856,751 | IONS, INCY, NBIX, VRTX | 13F-HR | 8/14/2019 | 000095012319008245 |
| Q1 2019 | 137 | 1,817,421 | ALGN, ISRG, ABT, ILMN | 13F-HR | 5/15/2019 | 000095012319005350 |
| Q4 2018 | 138 | 1,520,968 | ILMN, ABT, ISHARES TR NASDAQ BIOTECH, ISRG | 13F-HR | 2/12/2019 | 000095012319001355 |
| Q3 2018 | 138 | 1,576,423 | ELV, ALGN, ABT, CELG | 13F-HR | 11/13/2018 | 000095012318011222 |
| Q2 2018 | 138 | 1,172,986 | ELV, ALGN, CELG, ISRG | 13F-HR | 8/7/2018 | 000095012318007508 |
| Q1 2018 | 124 | 1,009,379 | ALGN, ELV, CELG, ISRG | 13F-HR | 5/9/2018 | 000095012318004458 |
| Q4 2017 | 134 | 957,226 | CELG, ELV, ALGN, ISRG | 13F-HR | 2/14/2018 | 000095012318002378 |
| Q3 2017 | 131 | 956,149 | CELG, AMGN, ALGN, GILD | 13F-HR | 11/13/2017 | 000095012317010308 |
| Q2 2017 | 132 | 845,728 | CELG, AMGN, MDT, UNH | 13F-HR | 8/14/2017 | 000095012317007847 |
| Q1 2017 | 132 | 750,418 | CELG, AMGN, INCY, CNC | 13F-HR | 5/11/2017 | 000095012317004497 |
| Q4 2016 | 122 | 488,317 | CELG, SYK, MDT, UNH | 13F-HR | 2/10/2017 | 000095012317001410 |
| Q3 2016 | 121 | 553,497 | MDT, SYK, CELG, ILMN | 13F-HR | 11/10/2016 | 000095012316021740 |
| Q2 2016 | 124 | 531,462 | MDT, SYK, CELG, ABT | 13F-HR | 8/12/2016 | 000095012316019825 |
| Q1 2016 | 130 | 551,071 | GILD, CELG, MDT, BIIB | 13F-HR | 5/16/2016 | 000095012316017418 |